Expansion planned through opening own labs or through partnerships to cover all major territories over the next 24 months
CORE Diagnostics has announced the launch of two new labs in Delhi and Bengaluru, respectively, as part of their aggressive plans to expand their footprint in India and shift beyond their B2B offerings.
The new facilities are staffed with highly skilled and qualified pathologists and technicians and will provide a range of tests starting from health packages to launching reproductive testing to high-end molecular testing.
In addition to these owned and operated labs, CORE is also expanding through partnerships. They recently partnered with GJ Diagnostics Lab in Ludhiana to expand their presence across Punjab & with Institute of Liver and Biliary Sciences, New Delhi on Next Generation Sequencing (NGS) testing.
Commenting on the launch, Dinesh Chauhan, CEO, CORE Diagnostics, said, “We, at CORE, have constantly endeavored to ensure affordable and accessible high-end diagnostics to all. These two new labs are the first steps in our commitment to expand our presence and meet the increasing demand for high-quality diagnostics. With our investment in automation and our sustained efforts to bring in advanced testing in India, we are building customer touchpoints enabling a high-quality experience for our customers. We are delighted to be executing on our vision of making quality diagnostics accessible to more people through our partnerships and lab expansion plans. We look to provide timely & the highest quality of diagnostic services to over 300 Indian cities & to expand our presence in countries across Asia, Middle East & Africa.”
The Bangalore lab is the first major investment in South India and will also serve as a digital pathology hub.